Ontamalimab
N/A
Report date: 2022/07/04 19:38:02
Base Information
Drug NameOntamalimab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[41]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A
Develop Information
Active CompaniesShire
Inactive CompaniesPfizer IncTakeda Pharmaceutical Co Ltd
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A